https://www.marketscreener.com/quote/stock/TAKEDA-PHARMACEUTICAL-COM-6491073/news/Takeda-Pharmaceutical-Presents-Results-from-Lung-Portfolio-Including-Phase-1-2-Study-of-TAK-788-in-28697212/?utm_source=telegram&utm_medium=social&utm_campaign=share